Conference Lunch Symposium: From Innovation to Clinical Practice Quality, Robustness, and Readiness of Liquid Biopsy

Location: 10th annual meeting of the German Society of Pathology
Kongress am Park
Gögginger Str. 10
86159 Augsburg

https://www.pathology-congress.de/

Date: 28th of May 2026
Time: 12:45 – 13:45
Room: To be specified

This symposium will explore how liquid biopsy is moving from scientific innovation into routine clinical practice, with a particular focus on the conditions required for broader implementation. The discussion will address not only recent clinical advances, but also the practical questions that determine whether liquid biopsy can be adopted at scale across healthcare systems.

Attendees will gain:

• A current overview of the evolving clinical role of liquid biopsy across oncology, including where it is already adding value and where further evidence is still needed
  Insight into the key requirements for routine adoption, including assay quality, robustness, standardisation, and readiness for clinical decision-making
• A better understanding of how liquid biopsy compares with tissue testing in real-world practice, including implications for test selection, workflow integration, and complementary use
• Perspective on quality assurance, reimbursement, and implementation barriers that continue to shape access across different healthcare settings
• Practical learning from real-world case studies illustrating how liquid biopsy results can influence patient management and treatment decisions
• The opportunity to engage with leading experts on what is needed to translate liquid biopsy from promising innovation into dependable clinical practice